Kenvue Inc. (KVUE)KVUEKenvue Inc.

Balance Sheet

Assets, liabilities, and equity analysis

Quarterly Balance Sheet (USD)

Quarterly Report	TTM	03/29/2026	12/28/2025	09/28/2025	06/29/2025	03/30/2025	12/31/2024	09/29/2024	06/30/2024
Total Current Assets	5.795B	5.795B	5.697B	6.032B	5.854B	5.710B	5.525B	5.941B	5.881B
Cash & Cash Equivalents	1.075B	1.075B	1.062B	1.139B	1.070B	1.057B	1.070B	1.057B	1.014B
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	1.075B	1.075B	1.062B	1.139B	1.070B	1.057B	1.070B	1.057B	1.014B
Accounts Receivable	2.911B	2.911B	2.814B	2.947B	2.856B	2.817B	2.659B	2.854B	2.797B
Inventory	1.674B	1.674B	1.666B	1.794B	1.776B	1.680B	1.591B	1.820B	1.849B
Total Assets	26.854B	26.854B	27.076B	27.248B	27.132B	26.257B	25.601B	26.925B	26.443B
Property, Plant & Equipment	2.208B	2.208B	2.212B	2.092B	2.038B	1.927B	1.849B	1.776B	2.004B
Goodwill	9.376B	9.376B	9.509B	9.441B	9.486B	9.136B	8.843B	9.297B	8.973B
Intangible Assets	8.540B	8.540B	8.694B	8.716B	8.804B	8.586B	8.474B	8.887B	8.762B
Long-Term Investments	0.00	0.00	0.00	1.000M	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	5.896B	5.896B	5.945B	6.156B	5.988B	6.666B	5.739B	5.946B	5.937B
Accounts Payable	2.533B	2.533B	2.473B	2.445B	2.568B	2.332B	2.254B	2.274B	2.437B
Short-Term Debt	1.589B	1.589B	1.453B	1.913B	1.553B	2.431B	1.552B	1.648B	1.427B
Total Liabilities	16.246B	16.246B	16.311B	16.614B	16.402B	16.204B	15.933B	16.281B	16.265B
Long-Term Debt	7.072B	7.072B	7.071B	7.060B	7.057B	6.197B	6.942B	7.053B	7.051B
Total Debt	8.661B	8.661B	8.524B	9.109B	8.744B	8.853B	8.719B	8.827B	8.606B
Net Debt (Cash)	7.586B	7.586B	7.462B	7.970B	7.674B	7.796B	7.649B	7.770B	7.592B
Total Shareholders' Equity	10.608B	10.608B	10.765B	10.634B	10.730B	10.053B	9.668B	10.644B	10.178B
Common Stock	19.000M	19.000M	19.000M	19.000M	19.000M	19.000M	19.000M	19.000M	19.000M
Retained Earnings	-128.000M	-128.000M	-204.000M	-136.000M	-136.000M	-163.000M	-93.000M	7.000M	17.000M
Current Ratio	0.98	0.98	0.96	0.98	0.98	0.86	0.96	1.00	0.99
Debt to Equity Ratio	0.82	0.82	0.79	0.86	0.81	0.88	0.90	0.83	0.85

Annual Balance Sheet (USD)

Annual Report	12/28/2025	12/29/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Total Current Assets	5.697B	5.525B	6.138B	5.877B	4.927B	4.595B	—
Cash & Cash Equivalents	1.062B	1.070B	1.382B	1.231B	740.000M	618.000M	—
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	—
Cash & Short-Term Investments	1.062B	1.070B	1.382B	1.231B	740.000M	618.000M	—
Accounts Receivable	2.814B	2.659B	2.640B	2.297B	2.331B	2.130B	—
Inventory	1.666B	1.591B	1.851B	2.226B	1.702B	1.685B	180.000M
Total Assets	27.076B	25.601B	27.851B	27.316B	27.929B	29.177B	—
Property, Plant & Equipment	2.212B	1.849B	2.042B	1.820B	1.827B	1.957B	—
Goodwill	9.509B	8.843B	9.271B	9.185B	9.810B	10.326B	—
Intangible Assets	8.694B	8.474B	9.619B	9.853B	10.701B	11.610B	—
Long-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	—
Total Current Liabilities	5.945B	5.739B	5.481B	3.926B	4.042B	7.494B	—
Accounts Payable	2.473B	2.254B	2.489B	1.829B	1.827B	1.579B	—
Short-Term Debt	1.453B	1.552B	599.000M	0.00	0.00	0.00	—
Total Liabilities	16.311B	15.933B	16.640B	7.346B	7.530B	10.821B	—
Long-Term Debt	7.071B	6.942B	7.687B	8.930B	0.00	0.00	—
Total Debt	8.524B	8.719B	8.427B	9.046B	129.000M	0.00	—
Net Debt (Cash)	7.462B	7.649B	7.045B	7.815B	-611.000M	-618.000M	—
Total Shareholders' Equity	10.765B	9.668B	11.211B	19.970B	20.399B	18.356B	—
Common Stock	19.000M	19.000M	19.000M	0.00	0.00	0.00	—
Retained Earnings	-204.000M	-93.000M	429.000M	0.00	0.00	0.00	—
Current Ratio	0.96	0.96	1.12	1.50	1.22	0.61	—
Debt to Equity Ratio	0.79	0.90	0.75	0.45	0.01	0.00	—

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Kenvue Inc.

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

Summit, NJ

22,000 employees

www.kenvue.com

Consumer Defensive / Household & Personal Products

Sector: Consumer Defensive
Industry: Household & Personal Products
CEO: Kirk L. Perry

View full financials